Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Abbott Becomes CRM Player Overnight By Completing St. Jude Deal

06 Jan 2017

• By Reed Miller

Related Content

The Rumors Were True: Abbott Buys St. Jude For $25b To Create Third Cardiovascular Giant

29 Apr 2016

St. Jude Pauses LEADLESS II Trial Of Nanostim Following Reports Of Lost Telemetry

30 Oct 2016

Earnings Winners And Losers: BSX, BCR, NUVA, NVCR

03 Aug 2016

Final Countdown To St. Jude Acquisition – Abbott Scores US Antitrust Approval

28 Dec 2016

Related Companies

Abbott

Abbott

Medtronic plc

Boston Scientific Corporation

Medtronic plc

Boston Scientific Corporation

BIOTRONIK AG

LivaNova PLC

Additional Topics

M & A Deals Commercial Cardiovascular Medical Device

More from Cardiology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.